Michal Shapira

9PUBLICATIONS
15CO-AUTHORS
Acoustics and noise control (excl. architectural acoustics)Traditional, complementary and integrative medicine not elsewhere classifiedBiomaterialsMedical infection agents (incl. prions)Host-parasite interactions
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 18, 2026
eIF3 musketeers: loyal in health, rogue in disease, and redeemed by therapeutic targeting.

Reza Mohammadinejad, Dan Su, Fanglin Luo

|Dec 14, 2023
LeishIF4E2 is a cap-binding protein that plays a role in Leishmania cell cycle progression.

Nofar Baron, Rajaram Purushotham, Durgeshwar Pullaiahgari

|Dec 10, 2021
Characterization of an Atypical eIF4E Ortholog in Leishmania, LeishIF4E-6.

Nitin Tupperwar, Rohit Shrivastava, Nofar Baron

|Apr 30, 2021
LeishIF4E-5 Is a Promastigote-Specific Cap-Binding Protein in Leishmania.

Rohit Shrivastava, Nitin Tupperwar, Bar Schwartz

|Mar 24, 2021
Distinct features of the Leishmania cap-binding protein LeishIF4E2 revealed by CRISPR-Cas9 mediated hemizygous deletion.

Nofar Baron, Nitin Tupperwar, Irit Dahan

|Jan 27, 2021
ZnJ6 Is a Thylakoid Membrane DnaJ-Like Chaperone with Oxidizing Activity in Chlamydomonas reinhardtii.

Richa Amiya, Michal Shapira

Pageof 2